About Divis Pharmaceuticals
Divis Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 1992. It produces high-quality active pharmaceutical ingredients and intermediates. It operates on a B2B model. The company has 64 employees. Its Indian entity Satyadivis Pharmaceuticals Private Limited reported revenue of ₹67.35 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Active Ingredients. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Divis Pharmaceuticals produces high-quality active pharmaceutical ingredients and intermediates through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and active ingredients. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- Employees 64
- SectorsHealthcare
- Website divispharma.com
- Legal Name Satyadivis Pharmaceuticals Private Limited
- Date of Incorporation 27 Oct, 1992
- Jurisdiction Jinnaram, Telangana, India
- Annual Revenue₹67.35 Cr
FY 2024 · +2% YoY
- Net Profit₹16.57 Cr
FY 2024 · 25% margin
- EBITDA₹25.66 Cr
FY 2024 · 38% margin
- Employee Count64
Associated legal entities of Divis Pharmaceuticals
Divis Pharmaceuticals operates through Satyadivis Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Satyadivis Pharmaceuticals Private Limited CIN U24239TG1992PTC014939 | Active | 27 Oct 1992 | Jinnaram, Telangana | ₹67.3 Cr | 64 | 3 | View details |
Board of directors of Satyadivis Pharmaceuticals Private Limited (Divis Pharmaceuticals)
Satyadivis Pharmaceuticals Private Limited is the primary company behind Divis Pharmaceuticals. The board of Satyadivis Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Divi Satya Mohan, appointed in 1992. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Divi Satya Mohan DIN 00619966 | Managing Director | 27 Oct 1992 | 34 yrs | Satyadivis Pharmaceuticals Private Limited |
| Suryanarayana Simhadri DIN 01951750 | Additional Director | 30 Aug 2025 | 1 yr 2 mo | Satyadivis Pharmaceuticals Private Limited |
| Ramesh Babu Potluri DIN 00166381 | Additional Director | 19 Dec 2025 | 10 mo | Satyadivis Pharmaceuticals Private Limited |
Financials of Divis Pharmaceuticals
Figures of Satyadivis Pharmaceuticals Private Limited, the primary company behind Divis Pharmaceuticals, for FY 2024. Revenue was ₹67.35 Cr (+2% year on year). Net profit was ₹16.57 Cr (25% margin). EBITDA was ₹25.66 Cr (38% margin). Revenue has grown at a compounded annual rate of +6% over three years and +20% over five years.
- ₹67.35 CrRevenue · FY 2024 · +2% YoY
- ₹16.57 CrNet profit · 25% margin
- ₹25.66 CrEBITDA · 38% margin
- ₹76.5 LakhPaid-up capital
- 64Employees (provident fund records)
- +6%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Satyadivis Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Divis Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Divis Pharmaceuticals
Divis Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Divis Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Divis Pharmaceuticals
Divis Pharmaceuticals was founded in 1992.
Divis Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Divis Pharmaceuticals has 64 employees.
The primary company behind Divis Pharmaceuticals, Satyadivis Pharmaceuticals Private Limited, reported revenue of ₹67.35 Cr for FY 2024, up 2% year on year.
Divis Pharmaceuticals produces high-quality active pharmaceutical ingredients and intermediates through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and active ingredients. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Divis Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Divis Pharmaceuticals operates through Satyadivis Pharmaceuticals Private Limited.
The legal entities of Divis Pharmaceuticals currently have 3 directors, including Divi Satya Mohan, Suryanarayana Simhadri, Ramesh Babu Potluri.